Dermatology NewsMethotrexate users need tuberculosis tests in high-TB areasNovember 8, 2020Psoriatic ArthritisPediatricsAutoimmune DiseasesPsoriasisInfectious Diseases
Dermatology NewsCOVID-19 risks in rheumatic disease remain unclearNovember 7, 2020Psoriatic ArthritisCOVID-19 Updates
Dermatology NewsTopical tapinarof effective in pivotal psoriasis trialsNovember 6, 2020PsoriasisPsoriatic Arthritis
Dermatology NewsBiologics may protect psoriasis patients against severe COVID-19November 2, 2020COVID-19 UpdatesPsoriasisPsoriatic Arthritis
Dermatology NewsMirikizumab beats placebo, secukinumab for psoriasisNovember 2, 2020PsoriasisPsoriatic Arthritis
Dermatology NewsData on potential risks of COVID-19 in psoriasis patients limited, but reassuringOctober 23, 2020PsoriasisCOVID-19 UpdatesPsoriatic Arthritis
Dermatology NewsNon-Whites remain sorely underrepresented in phase 3 psoriasis trialsOctober 20, 2020PsoriasisPsoriatic Arthritis
Dermatology NewsGuselkumab improvements for psoriatic arthritis persist through 1 yearOctober 15, 2020Psoriatic Arthritis
Dermatology NewsStudy highlights differences between White and Latino patients with psoriasisOctober 6, 2020PsoriasisPsoriatic Arthritis
Experts assess infection risks for patients on biologicsOctober 6, 2020Psoriatic ArthritisInfectious Diseases
Dermatology NewsShingrix effective in older adults with preexisting immune-mediated disordersOctober 5, 2020Psoriatic ArthritisPsoriasis
Dermatology NewsGolimumab approval extended to polyarticular-course JIA and juvenile PsAOctober 2, 2020Psoriatic ArthritisPediatricsRare Diseases
Dermatology NewsPregnancy studies on psoriasis, PsA medications pick upOctober 1, 2020PsoriasisPsoriatic Arthritis
Dermatology NewsStudy results suggest ustekinumab may trigger acute CV events early in treatmentSeptember 18, 2020PsoriasisPsoriatic Arthritis
